Surface coating of cardiopulmonary bypass circuits

Kurusz M. , Wheeldon DR Risk containment during cardiopulmonary bypass. Semin Thorac Cardiovasc Surg 1990; 2: 400-409.

Müller-Glauser W. , Lehmann KH , Bittmann P. et al. A compliant small diameter vascular prosthesis lined with functional venous endothelial cells . Trans Am Soc Artif Intern Organs 1988; 34: 528-31.

Pasic M. , Müller-Glauser W. , von Segesser LK et al. Superior late patency of small diameter Dacron grafts seeded with omental microvascular cells: an experimental study. Ann Thorac Surg 1994; 58: 677-84.

Dasse KA , Chipman SD , Sherman CN et al. Clinical experience with textured blood contacting surface in ventricular assist devices. ASAIO J 1987; 10: 418-25.

Gott VL , Whiffen JD , Datton RC Heparin bonding on colloidal graphite surfaces. Science 1963; 142: 1297-98.

Larm O. , Larsson R. , Olsson P. A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomater Med Devices Artif Org 1983; 11: 161-73.

Tong SD , Rolfs MR , Hsu LC Evaluation of Duraflo II heparin immobilized cardiopulmonary bypass circuits . ASAIO J 1990; 36: 654-56.

Josefowicz M. , Jozefonvicz J. New approaches to anticoagulation: heparin-like biomaterials. ASAIO J 1985; 8: 218-22.

Chapman D. , Charles SA A coat of many lipids - in the clinic. Chemistry in Britain 1992; 3: 253-56.

Yianni YP Biocompatible surfaces based upon biomembrane mimicry. In: Quinn PJ , Cherry RJ eds. Structural and dynamic properties of lipids and membranes. London: Portland Press Ltd, 1992 : 187-217.

Conolly RJ , Anderson JM , Kambic HE et al. Small diameter vascular protheses. Trans Am Soc Artif Intern Organs 1988; 34: 1043-46.

von Segesser LK , Weiss B. , Turina MI Perfusion with heparin coated equipment: potential for clinical use. Semin Thorac Cardiovasc Surg 1990; 2: 373-80.

von Segesser LK , Schilling J. , Leskosek B. , Marquardt K. , Turina MI Surface treatments for perfusion devices. Perfusion 1994; 9: 197-205.

von Segesser LK , Weiss BM , Garcia E. et al. Reduction and elimination of systemic heparinization during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1992; 103: 790-99.

von Segesser LK , Weiss BM , Pasic M. , Garcia E. , Turina MI Risk and benefit of low systemic heparinization during open heart surgery. Ann Thorac Surg 1994; 58: 391-98.

von Segesser LK , Tönz M. , Leskosek B. , Turina M. Evaluation of phospholipid surface coatings ex-vivo. Int J Artif Org 1994; 17: 294-300.

von Segesser LK , Weiss BM , Garcia E. , Turina MI Clinical application of heparin coated perfusion equipment with special emphasis on patients refusing homologous transfusions . Perfusion 1991; 6: 227-33.

Gu YJ , van Oeveren W. , Akkerman C. et al. Heparin coated circuits reduce the inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993 ; 55: 917-22.

Videm V. , Svennevig JL , Fosse E. et al. Reduced complement activation with heparin coated oxygenator and tubings in coronary bypass operations. J Thorac Cardiovasc Surg 1992; 103: 806-13.

Steinberg BM , Grossi EA , Schwartz DS et al. Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass . Ann Thorac Surg 1995; 60: 525-29.

Nilsson L. , Peterson C. , Venge P. et al. Eosinophil granule proteins in cardiopulmonary bypass with and without heparin coating. Ann Thorac Surg 1995 ; 59: 713-16.

von Segesser LK , Olah A. , Leskosek B. , Turina M. Coagulation patterns in bovine left heart bypass with phospholipid versus heparin surface coating . ASAIO J 1993; 39: 43-46.

Hunter S. , Angelini GD Phosphatidylcholine coated chest tubes improve drainage after open heart operation . Ann Thorac Surg 1993; 56: 1339-42.